Clinical Oncology

Papers
(The H4-Index of Clinical Oncology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The Time has Come to Say Goodbye120
Dose Accumulation for Pelvic Stereotactic Ablative Body Radiotherapy Reirradiation. In Regard to Slevin et al.70
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re57
OncoFlash: Research Updates in a Flash!49
The “real” outcome of esophageal cancer in elderly.33
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)32
Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis31
OncoFlash—Research Updates in a Flash!30
Novel Therapies in Triple-negative Breast Cancer: Can less be More?29
Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access29
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas27
OncoFlash - Research Updates in a Flash! (Sep 2025)27
Vascular Interventions in Oncology25
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital24
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year23
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma23
OncoFlash – Research Updates in a Flash! (June 2022)23
Instant Oncology: Impower13322
OncoFlash–Research Updates in a Flash! (December 2022)21
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre21
Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines21
0.14867401123047